Group 1 - The core viewpoint of the article highlights the robust performance of Pakistan's marine fisheries sector, with seafood export volume reaching approximately 123,000 tons and export value exceeding $250 million, reflecting a year-on-year increase of 19.1% and 21.6% respectively for the first half of the fiscal year 2025-2026 [1][2] - The fisheries sector is a crucial pillar of Pakistan's marine economy, providing livelihoods for hundreds of thousands in coastal regions, particularly benefiting Sindh and Balochistan provinces [1] - The industry has gradually recovered by expanding processing capacity, improving cold chain logistics, and implementing strict international certification standards [1] Group 2 - The export product mix is diverse, with frozen fish as the core export category, accounting for approximately 27,000 tons and over $53 million in export value; shrimp products follow as the second-largest category with an export value exceeding $40 million [1] - Other contributing products to export value growth include shrimp meal, crab, sardines, mackerel, flounder, and fish meal, indicating a trend towards diversification in the seafood value-added processing sector [1] - China remains the largest seafood export market for Pakistan, with imports exceeding 83,000 tons and an import value of around $150 million, representing nearly 59% of Pakistan's total seafood export value during the period [2]

近日，广东珠海市平岗泵站二期扩建工程正式通水。作为珠澳原水系统的"动力心脏"，平岗泵站取 水能力将提升至每日360万吨，规模达原来的2.6倍，大幅提升了咸潮期珠海"抢淡压咸"能力，为珠澳两 地应对咸潮侵袭、饮用水安全增添了坚实保障，造福了两地320万居民。 （责任编辑：张晓波 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 在"十四五"圆满收官、"十五五"开局起步之际，广东水利系统紧紧围绕全国水利工作会议的要求， 抢抓冬春水利建设黄金施工期，压实责任，细化方案，多措并举，推进水利工程建设全面提速。 农村水利工作持续巩固提升。广东不断加大农田水利基础设施的投入，全省耕地有效灌溉面积占耕 地面积的比重达81%。持续实施一批中型灌区现代化改造项目，下达中央资金的4宗项目已全部开工建 设。以"严"为底线，近远结合，坚决做好农村供水保障。近期针对春节人流潮汐，编制应急预案，做足 物资储备，抓好宣传引导，做好应急 ...

南模生物首次公开发行股票募集资金总额为16.49亿元，扣除发行费用后募集资金净额为14.68亿 元。南模生物最终募集资金净额比原计划多10.68亿元。南模生物于2021年12月23日披露的招股说明书 显示，该公司拟募集资金4.00亿元，分别用于上海砥石生物科技有限公司生物研发基地项目（南方模式 生物）、基因修饰模型资源库建设项目、人源化抗体小鼠模型研发项目、基于基因修饰动物模型的药效 平台建设项目、补充流动资金项目。 南模生物首次公开发行股票的发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。 (责任编辑：徐自立) 南模生物于2021年12月28日在上交所科创板上市，发行股票数量为1949.09万股，发行价格为 84.62元/股，保荐人（主承销商）为海通证券股份有限公司（现更名为国泰海通证券股份有限公司）， 保荐代表人为张子慧、陈亚聪。 南模生物上市首日盘中最高价报82.00元，为该股上市以来最高价。该股目前处于破发状态。 中国经济网北京1月22日讯 南模生物(688265.SH)今日股价下跌，收报48.21元，跌幅3.17%。 ...

吉华集团发行费用总额为8,751.76万元，其中承销保荐费7,795.57万元。 2018年年度权益分派实施公告显示，本次利润分配及转增股本以方案实施前的公司总股本 500,000,000股为基数，每股派发现金红利0.45元（含税），以资本公积金向全体股东每股转增0.4股， 共计派发现金红利225,000,000元，转增200,000,000股，本次分配后总股本为700,000,000股。 中国经济网北京1月22日讯 吉华集团(603980.SH)今日收报5.75元，跌幅3.20%。目前该股处于破 发状态。 吉华集团于2017年6月15日在上交所主板上市，发行数量为10,000万股，发行价格为17.20元/股， 保荐机构（主承销商）为安信证券股份有限公司（现为"国投证券股份有限公司"），保荐代表人为袁 弢、湛瑞锋。 吉华集团首次公开发行募集资金总额172,000.00万元，扣除发行费用后，募集资金净额为 163,248.24万元，分别用于"年产11250吨高性能分散染料、7500吨高溶解性高强度酸性系列染料、 11250吨高溶解性高强度直接系列染料、10000吨活性系列染料项目""年产3000吨1-氨基蒽醌技 ...

中国经济网北京1月22日讯 智翔金泰(688443.SH)今日股价下跌，截至收盘，该股报28.85元，跌 幅1.74%。该股目前处于破发状态。 智翔金泰于2023年6月20日在上交所科创板上市，公开发行新股9,168.0000万股，发行价格为 37.88元/股，保荐机构（主承销商）为海通证券股份有限公司（现名"国泰海通证券股份有限公司"）， 保荐代表人为王永杰、刘丹。 2025年前三季度，智翔金泰实现营业收入2.08亿元，同比增长1,562.05%；实现归属于上市公司股 东的净利润-3.33亿元；实现归属于上市公司股东的扣除非经常性损益的净利润-3.70亿元；经营活动产 生的现金流量净额为-2.61亿元。 (责任编辑：徐自立) 智翔金泰首次公开发行股票的发行费用合计18,143.70万元（不含税），其中，保荐承销费 16,495.98万元。 智翔金泰已连亏4年3季。2021年至2024年，智翔金泰归属于上市公司股东的净利润分别为-3.22亿 元、-5.76亿元、-8.01亿元、-7.97亿元；归属于上市公司股东的扣非净利润分别为-3.34亿元、-6.45亿 元、-8.13亿元、-8.04亿元。 智翔金泰首次公 ...

Group 1 - The core point of the article is that Chengda Pharmaceutical (301201.SZ) is currently experiencing a decline in stock price, with a closing price of 39.67 yuan and a drop of 4.16%, indicating that the stock is in a state of breaking its initial public offering (IPO) price [1] - Chengda Pharmaceutical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on January 20, 2022, with an initial public offering of 24,174,035 shares at a price of 72.69 yuan per share [1] - On its first day of trading, the stock reached a peak price of 188.00 yuan, which remains the highest point since its listing [1] Group 2 - The total amount raised from the IPO was 1,757.21 million yuan, with a net amount of 1,621.45 million yuan after deducting issuance costs [1] - The actual net fundraising amount exceeded the originally planned amount by 1,108.17 million yuan, with the initial target set at 513.28 million yuan for projects including "pharmaceutical intermediates, raw materials, and R&D center expansion" as well as "supplementing working capital" [1] - The total issuance costs for the IPO were 135.76 million yuan, with underwriting fees amounting to 117.93 million yuan [2] Group 3 - The actual controllers of Chengda Pharmaceutical are Ge Jianli, Lu Gang, and Lu Jin, with Lu Jin being a Chinese national who holds permanent residency in Canada [3] - On July 3, 2023, the company announced its 2022 annual equity distribution plan, which involves a cash distribution of 3.00 yuan for every 10 shares and a capital reserve increase of 6.00 shares for every 10 shares [3] - The record date for the equity distribution was set for July 6, 2023, with the ex-dividend date on July 7, 2023 [3]

Core Insights - QCraft has announced the mass production of the industry's first city NOA solution based on a single Horizon 6M chip, which is now available in the Li Auto L series [1] - The solution utilizes 128 TOPS computing power to deliver an advanced urban NOA experience, emphasizing the efficient use of computing resources [1] - QCraft's co-founder and CEO, Dr. Yu Qian, highlighted the company's pioneering approach in identifying the potential of a single chip for urban NOA and achieving high performance [1] Group 1 - The mass production solution is based on QCraft's innovative end-to-end safety model, which comprehensively covers urban travel scenarios [1] - The system features human-like defensive driving capabilities, ensuring safety throughout the driving process by anticipating and mitigating risks in complex environments [2] - The safety model integrates with the vehicle's HMI, providing real-time insights into system decision-making, moving away from traditional "black box" models [4] Group 2 - The solution is designed to efficiently handle various urban driving scenarios, including traffic lights and city cruising, by automatically adjusting driving rhythms [6] - The system's smooth action planning enhances passenger comfort by avoiding abrupt stops and hesitations in complex situations [6] - The successful mass production of the single Horizon 6M city NOA demonstrates QCraft's capabilities in large-scale production and optimization, making advanced driving assistance more accessible to a wider range of vehicles [6]

中国经济网北京1月22日讯 赛力斯（港股代码09927.HK）港股收报102.50港元，跌幅2.751%，创 港股上市以来新低。赛力斯港股上市累计跌幅22.05%。 赛力斯的基石投资者为重庆产业母基金、林园基金及华泰资本投资（与华泰背对背总回报掉期及林 园总回报掉期有关）、广发基金管理有限公司及广发国际资产管理有限公司（统称为"广发基金"）、 New China Asset Management、BESS Broadway、Sanhua (Hong Kong)、中升、Zhink International、Gold Wings、达安投资、Hichain Logistics HK、施罗德、Mirae Securities、New Alternative、中邮理财、Skyler International、星宇香港、中国美东、Ghisallo Fund、Jump Trading、 Jain Global Master Fund Ltd、China Alpha Fund。 其中，New China Asset Management由新华人寿保险股份有限公司（简称"新华保险"， 1336.HK，601336.SH）直 ...

Core Viewpoint - Longqi Technology Co., Ltd. (龙旗科技) successfully listed on the Hong Kong Stock Exchange, closing at HKD 32.10 with a gain of 3.55% on the first trading day [1] Group 1: IPO Details - The total number of shares offered globally was 52,259,100 H-shares, with 5,226,000 shares allocated for the Hong Kong offering and 47,033,100 shares for international offering [1] - The final offer price was set at HKD 31.00, raising a total of HKD 1,620.0 million, with net proceeds amounting to HKD 1,519.9 million after deducting estimated listing expenses of HKD 100.1 million [6][7] Group 2: Use of Proceeds - The net proceeds from the global offering will be used to expand the company's overall production capacity both domestically and internationally, support ongoing R&D efforts, enhance marketing and customer development, and fund strategic investments or acquisitions globally, along with general corporate purposes [7] Group 3: Key Investors - Notable cornerstone investors include Qualcomm Ventures LLC, Jiangxi Guokong Private Equity Fund Management, Veer Semiconductor Hong Kong Limited, Hong Kong Yutong Printing Co., Ltd., Qingdao Guanlan, and Guotai Junan Securities Investment (Hong Kong) Co., Ltd. [5] Group 4: Future Plans - Longqi Technology plans to list on the Shanghai Stock Exchange on March 1, 2024, with an issuance of 60 million shares at a price of RMB 26.00 per share, representing 12.90% of the post-issue total share capital [7]

Core Viewpoint - The major shareholders of Qingmu Technology have completed their share reduction plan, resulting in a significant decrease in their ownership percentage, which now stands at 42.51% of the total shares outstanding [1] Group 1: Share Reduction Details - The share reduction plan was initially announced on September 29, 2025, allowing for a maximum reduction of 2,776,000 shares, representing up to 3.00% of the total share capital [1] - The reduction was executed through various transactions: 1,647,000 shares were sold via block trading at an average price of 63.28 CNY per share, and 818,868 shares were sold through centralized bidding at an average price of 92.30 CNY per share [2][3] - The total cash generated from the share reduction is approximately 200 million CNY [3] Group 2: Company Background - Qingmu Technology was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on March 11, 2022, with an initial public offering of 16.67 million shares at a price of 63.10 CNY per share [4] - The total funds raised from the IPO amounted to 1.052 billion CNY, with a net amount of 951 million CNY after expenses, exceeding the initial plan by 311 million CNY [4] - The funds raised are intended for various projects, including the construction of an e-commerce service operation center and upgrades to consumer data platforms [4]